Scalper1 News
Drugmaker Perrigo (PRGO) beat Wall Street’s Q4 expectations Thursday morning, sending the stock up 6% on the stock market today even though its 2015 guidance missed estimates. Sales for the quarter ended June 28 rose 18% over the year-earlier quarter to $1.14 billion, beating analysts’ consensus of $1.09 billion. Profit jumped 58% to $1.74 per share, excluding one-time items, topping the Street’s average estimate by 19 cents. The company did not Scalper1 News
Scalper1 News